Entry Point Capital, LLC Legend Biotech Corp Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 2,850 shares of LEGN stock, worth $143,383. This represents 0.18% of its overall portfolio holdings.
Number of Shares
2,850
Previous 176
1519.32%
Holding current value
$143,383
Previous $9.87 Million
1178.64%
% of portfolio
0.18%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
198Shares Held
74.2MCall Options Held
374KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$578 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$378 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$334 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$288 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.77MShares$240 Million1.06% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $8.42B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...